VEGF receptor signalling ? in control of vascular function
The DOI matches its Crossref record; 140 of the 141 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Vascular endothelial growth-factor receptors (VEGFRs) regulate the cardiovascular system. VEGFR1 is required for the recruitment of haematopoietic precursors and migration of monocytes and macrophages, whereas VEGFR2 and VEGFR3 are essential for the functions of vascular endothelial and lymphendothelial cells, respectively. Recent insights have shed light onto VEGFR signal transduction and the interplay between different VEGFRs and VEGF co-receptors in development, adult physiology and disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These proteins collectively contribute to promoting angiogenic activities by influencing endothelial cell proliferation [49,53,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Moreover, EVs’ content also encompasses an array of growth factors such as soluble growth factors like VEGF, TGFB1, IL-8, and HGF.”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Additionally, miRNAs cargos in MSCs EVs such as miR210, miR126, miR132, and miR21 have been identified as contributors to angiogenesis [49,54].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [54]
In the citing paper
“Flt-1 is one of the main receptors of the vascular endothelial growth factor (VEGF) family widely expressed in the vascular system.33”
From CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease (2018) · cites this paper as [33]
Citations
Cites
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
Jain, R. K. (2005) · Science · doi:10.1126/science.1104819 · Cited by 5,527
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundTumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,972
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Circulating angiogenic factors and the risk of preeclampsia
Levine, R. J., Maynard, S. E., Qian, C., Lim, K.-H., England, L. J., Yu, K. F., Schisterman, E. F., Thadhani, R., Sachs, B. P., Epstein, F. H., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031884 · Cited by 3,720
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628 · cited 1×
“Inactivation of a single Vegfa allele in mice results in early lethality at embryonic day (E)11?12 owing to deficient endothelial-cell development and lack of vessel”
BackgroundVEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., MacDonald, D. D., Jin, D. K., Shido, K., Kerns, S. A., et al. (2005) · Nature · doi:10.1038/nature04186 · Cited by 3,288
Circulating angiogenic factors and the risk of preeclampsia*
(2004) · Obstetrics & Gynecology · doi:10.1097/00006250-200405000-00028 · Cited by 2,615
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D., Gratton, J.-P., McCabe, T. J., Fontana, J., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,608
Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606
Cited by
Items 501–600 of 1,013
Chien, M., Ku, C., Johansson, G., Chen, M.-W., Hsiao, M., Su, J.-L., Inoue, H., Hua, K., Wei, L., & Kuo, M. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp244 · Cited by 82
Current management of benign bile duct strictures.
Lillemoe, K. D., Pitt, H. A., & Cameron, J. L. (1992) · PubMed · Cited by 95
Stromal Modulation Reverses Primary Resistance to Immune Checkpoint Blockade in Pancreatic Cancer
Zhao, J., Xiao, Z., Li, T., Chen, H., Yuan, Y., Wang, Y., Hsiao, C.-H., Chow, D. S., Overwijk, W. W., & Li, C. (2018) · ACS Nano · doi:10.1021/acsnano.8b02481 · Cited by 84
Marina, M. E., Roman, I. I., Constantin, A.-M., Mihu, C. M., & Tataru, A. D. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-494 · Cited by 81
“VEGFR-1 acts during embryogenesis for normal blood vessel development, VEGFR-2 determines the proliferation and the migration of ECs as well as the increased vascular permeability [3,7,14].”
BackgroundIdentification of a clonally expanding haematopoietic compartment in bone marrow
Wang, L., Benedito, R., Bixel, M. G., Zeuschner, D., Stehling, M., Savendahl, L. S., Haigh, J. J., Snippert, H. J. G., Clevers, H. C., Breier, G., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.308 · Cited by 88
“Tissue-derived VEGF family growth factors and their endothelial receptors— most importantly, the ligand-receptor pair VEGF-A and VEGFR2/Flk1—are key regulators of angiogenic blood vessel growth both under physiological and pathological conditions (Olsson et al , 2006; Carmeliet and Jain, 2011).”
VEGF, HIF-1α Expression and MVD as an Angiogenic Network in Familial Breast Cancer
Saponaro, C., Malfettone, A., Ranieri, G., Danza, K., Simone, G., Paradiso, A., & Mangia, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053070 · Cited by 93
“The interaction between VEGF and VEGFR-2 activates tyrosine amino acid residues contained by the intracytoplasmatic tail of the receptor, triggering off different signaling cascades in endothelial cells such as survival, proliferation, migration and vascular permeability [16,17].”
BackgroundRole of Inflammation in Diabetic Macular Edema
Noma, H., Mimura, T., Yasuda, K., & Shimura, M. (2014) · Ophthalmologica · doi:10.1159/000364955 · Cited by 85
Peng, F.-W., Ji, X., Wu, T.-T., Xue, J., Ren, Z., Liu, D., Wang, X., Chen, X.-H., Zhang, J., Xu, Y., et al. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.12.033 · Cited by 83
Deloulme, J., Gory‐Fauré, S., Mauconduit, F., Chauvet, S., Jonckheere, J., Boulan, B., Mire, E., Xue, J., Jany, M., Maucler, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms8246 · Cited by 86
Dohlman, T. H., Omoto, M., Hua, J., STEVENSON, W. C., Lee, S. M., Chauhan, S. K., & Dana, R. (2015) · Transplantation · doi:10.1097/tp.0000000000000512 · Cited by 83
“© 2015 Wolters Kluwer Dohlman et al 679 promoting allosensitization and effector cell homing to the graft.3 Both hemeangiogenesis and lymphangiogenesis are principally coordinated by the VEGF family of receptors and ligands, with hemangiogenesis largely driven by VEGF-A binding to VEGFR-1 and VEGFR-2 and lymphangiogen…”
BackgroundPro-angiogenic therapeutics for preeclampsia
Eddy, A. C., Bidwell, G. L., & George, E. M. (2018) · Biology of Sex Differences · doi:10.1186/s13293-018-0195-5 · Cited by 81
Kan, J., Guo, W., Huang, C., Bao, G., Zhu, Y. Z., & Zhu, Y. Z. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5449 · Cited by 83
“Vascular endothelial growth factor (VEGF) is the crucial regulator of angiogenesis that primarily binds to two related receptor tyrosine kinases (RTKs), known as VEGFR1 (Flt-1) and VEGFR2 (KDR or Flk-1) (8, 20).”
BackgroundCurrent Progress in Targeted Therapy for Colorectal Cancer
Ortega, J., Vigil, C. E., & Chodkiewicz, C. (2010) · Cancer Control · doi:10.1177/107327481001700102 · Cited by 85
Potential role of hydrogen sulfide in diabetes-impaired angiogenesis and ischemic tissue repair
Cheng, Z. A., & Kishore, R. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101704 · Cited by 84
“Most studies focused on the VEGF signaling in angiogenic response [125,133, 134].”
BackgroundCheng, Y., Hsieh, M. L., Lin, C., Chang, C. M., Huang, C.-Y., Puntney, R., Moy, A., Ting, C.-Y., Chan, D. Z. H., Nicholson, M. W., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061736 · Cited by 87
“13,14 Previous studies have shown that ECs promote CM survival and organization in culture.”
BackgroundBiomarkers as outcome predictors in subarachnoid hemorrhage – a systematic review
Hong, C. M., Tosun, Ç., Kurland, D. B., Gerzanich, V., Schreibman, D. L., & Simard, J. M. (2014) · Biomarkers · doi:10.3109/1354750x.2014.881418 · Cited by 86
“VEGF and other vascular mitogens are regulated by circulating antiangiogenic factors, soluble-fmslike tyrosine kinase 1 (sFlt1) (Olsson et al., 2006) and soluble endoglin (sEng) (Bernabeu et al.”
BackgroundChen, M., Lee, C.-F., Huang, W., & Chou, T. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.009 · Cited by 80
Zou, G.-M., Karikari, C. A., Kabe, Y., Handa, H., Anders, R. A., & Maitra, A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21666 · Cited by 80
“…OF CELLULAR PHYSIOLOGY Flt-1 (VEGFR1), the expression of Flk-1 is restricted to hemangioblasts and their differentiated endothelial progeny, and signal transduction through this receptor subsequent to VEGF ligand binding acts a potent mitogen for endothelial cells (Olsson et al., 2006).”
BackgroundThe Adaptation of the Cerebral Circulation to Pregnancy: Mechanisms and Consequences
Cipolla, M. J. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.210 · Cited by 87
Ivaska, J., & Heino, J. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0857-z · Cited by 93
“Neuropilin-1 is a transmembrane glycoprotein that functions as an adhesion receptor and a co-receptor for both pro- and anti-angiogenic factors (Olsson et al. 2006; Shimizu et al. 2000).”
BackgroundKazerounian, S., Duquette, M. A., Reyes, M. A., Lawler, J. T., Song, K., Perruzzi, C. A., Primo, L., Khosravi‐Far, R., Bussolino, F., Rabinovitz, I., et al. (2011) · Blood · doi:10.1182/blood-2010-09-305284 · Cited by 83
Vascular Endothelial Growth Factor A Inhibition in Gastric Cancer
Park, D. J., Thomas, N. J., Yoon, C., & Yoon, S. S. (2014) · Gastric Cancer · doi:10.1007/s10120-014-0397-4 · Cited by 93
“seven extracellular immunoglobulin-like domains, a transmembrane region, and an intracellular consensus tyrosine kinase domain [6].”
BackgroundKurenova, E., Hunt, D. L., He, D.-H., Magis, A. T., Ostrov, D. A., & Cance, W. G. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900159g · Cited by 80
Endothelial Fatty Acid Transport: Role of Vascular Endothelial Growth Factor B
Hagberg, C., Mehlem, A., Falkevall, A., Muhl, L., & Eriksson, U. (2013) · Physiology · doi:10.1152/physiol.00042.2012 · Cited by 78
Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches
Gabhann, F. M., & Popel, A. S. (2006) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020180 · Cited by 79
“[7,8].”
Gavard, J., Hou, X., Qu, Y., Masedunskas, A., Martı́n, D., Weigert, R., Li, X., & Gutkind, J. S. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01304-08 · Cited by 80
Tian, T., Nan, K., Wang, S., Liang, X., Lu, C.-X., Guo, H., Wang, W., & Ruan, Z. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq085 · Cited by 84
Glucose, Insulin, and Oxygen Interplay in Placental Hypervascularisation in Diabetes Mellitus
Cvitic, S., Desoye, G., & Hiden, U. (2014) · BioMed Research International · doi:10.1155/2014/145846 · Cited by 75
VEGFR‐2 expression in carcinoid cancer cells and its role in tumor growth and metastasis
Silva, S. R., Bowen, K. A., Rychahou, P. G., Jackson, L. N., Weiss, H. L., Lee, E. Y., Townsend, C. M., & Evers, B. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25441 · Cited by 80
“VEGFR-2, also designated as kinase domain receptor (KDR), is a tyrosine kinase that can signal through the phosphatidylinositol-3-kinase/protein kinase B (PI3K/Akt) pathway.(9,10) When VEGF binds to its receptor, it activates the PI3K protein, which is made up of a p85 regulatory subunit and a p110 catalytic subunit.”
BackgroundMechanisms of three-dimensional growth of thyroid cells during long-term simulated microgravity
Kopp, S., Warnke, E., Wehland, M., Aleshcheva, G., Magnusson, N. E., Hemmersbach, R., Corydon, T. J., Bauer, J. W., Infanger, M., & Grimm, D. G. (2015) · Scientific Reports · doi:10.1038/srep16691 · Cited by 87
Angiogenesis: Managing the Culprits behind Tumorigenesis and Metastasis
Yehya, A. H. S., Asif, M., Petersen, S. H., Subramaniam, A. V., Kono, K., Majid, A. M. S. A., & Oon, C. E. (2018) · Medicina · doi:10.3390/medicina54010008 · Cited by 92
Association of serum VEGF levels with prefrontal cortex volume in schizophrenia
Pillai, A., Howell, K. R., Ahmed, A. O., Weinberg, D., Allen, K. M., Bruggemann, J. M., Lenroot, R., Liu, D., Galletly, C. A., Weickert, C. S., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.96 · Cited by 83
A perspective on the role of class III semaphorin signaling in central nervous system trauma
Mecollari, V., Nieuwenhuis, B., & Verhaagen, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00328 · Cited by 79
“One of the other molecules that signals via NRPs are VEGFs (reviewed in Olsson et al., 2006) and compete with SEMA3s for NRP binding (Gu et al., 2002; Appleton et al., 2007).”
BackgroundInfluentialEngineering Synthetic Signaling Pathways with Programmable dCas9-Based Chimeric Receptors
Baeumler, T. A., Ahmed, A. A., & Fulga, T. A. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.044 · Cited by 84
“See also Figures S1 and S2. immunoglobulin homology repeats (Olsson et al., 2006).”
BackgroundWise, L. M., Inder, M. K., Real, N. C., Stuart, G. S., Fleming, S. B., & Mercer, A. A. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01802.x · Cited by 89
“In this study, using quantitative RT-PCR, we detected expression of VEGFR-1, VEGFR-2, VEGFR-3 and NRP-1 in HaCaT cells.”
BackgroundInfluentialRossiter, H., Barresi, C., Ghannadan, M., Грубер, Ф., Mildner, M., Födinger, D., & Tschachler, E. (2007) · The FASEB Journal · doi:10.1096/fj.07-8720com · Cited by 79
Magnusson, P. U., Looman, C., Åhgren, A., Wu, Y., Claesson-Welsh, L., & Heuchel, R. L. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000282198.60701.94 · Cited by 78
Wu, F. T. H., Stefanini, M. O., Gabhann, F. M., & Popel, A. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005108 · Cited by 80
“alternative splicing of the VEGFR1 gene, but possibly with contributions from proteolytic shedding of the extracellular fragment of VEGFR1 as well [10–12].”
BackgroundEvidence for Pro-angiogenic Functions of VEGF-Ax
Xin, H., Zhong, C., Nudleman, E., & Ferrara, N. (2016) · Cell · doi:10.1016/j.cell.2016.08.054 · Cited by 87
“The binding of VEGF-A to its major tyrosine kinase receptor, VEGFR2, stimulates the proliferation of endothelial cells via the RAS/RAF/MEK/ERK signaling pathway (Herbert and Stainier, 2011; Olsson et al., 2006).”
BackgroundAflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway
Lazzara, F., Fidilio, A., Platania, C. B. M., Giurdanella, G., Salomone, S., Leggio, G. M., Tarallo, V., Cicatiello, V., Falco, S. D., Eandi, C. M., et al. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.07.021 · Cited by 80
Rahman, N., Purpura, K. A., Wylie, R. G., Zandstra, P. W., & Shoichet, M. S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.07.040 · Cited by 87
“VEGFR1 is mainly found on endothelial cells whereas VEGFR2 (also known as Flk-1 in mouse cells and KDR in human cells) is expressed on endothelial cells, hematopoietic stem cells, megakaryocytes, and osteoblasts [9].”
BackgroundZhang, B., Chamba, Y., Shang, P., Wang, Z., Ma, J., Wang, L., & Zhang, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-03976-3 · Cited by 86
Antibody variable region engineering for improving cancer immunotherapy
Lou, H., & Cao, X. (2022) · 癌症:英文版 · doi:10.1002/cac2.12330 · Cited by 80
Genome-Wide Analysis of miRNA-mRNA Interactions in Marrow Stromal Cells
Balakrishnan, I., Yang, X., Brown, J., Ramakrishnan, A., Torok‐Storb, B., Kabos, P., Hesselberth, J. R., & Pillai, M. M. (2013) · Stem Cells · doi:10.1002/stem.1531 · Cited by 81
Tafuro, S., Ayuso, E., Zacchigna, S., Zentilin, L., Moimas, S., Dore, F., & Giacca, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp152 · Cited by 78
Kwon, W., Moon, H. J., Kwon, T.-H., Park, Y., & Kim, J. H. (2017) · Neurosurgery · doi:10.1093/neuros/nyx149 · Cited by 78
Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis
Nan, W., He, Y., Wang, S., & Zhang, Y. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1234104 · Cited by 84
“Three distinct tyrosine kinase receptors are capable of interacting with VEGF ligands: the 1–3 VEGF receptors (also known as Flt1, Flk1, and Flt4) (Olsson et al., 2006).”
BackgroundSchreurs, M. P. H., Houston, E. M., May, V., & Cipolla, M. J. (2011) · The FASEB Journal · doi:10.1096/fj.11-191916 · Cited by 77
“VEGF-induced BBB permeability involves complex signaling by its two receptors (15); however, little is known about VEGFR activation that induces BBB permeability.”
BackgroundHypoxia-inducible factor in cancer angiogenesis: Structure, regulation and clinical perspectives
Otrock, Z. K., Hatoum, H. A., Awada, A. H., Ishak, R. S., & Shamseddine, A. I. (2009) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2009.01.001 · Cited by 87
“[70] Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L.”
BackgroundGuangqi, E., Cao, Y., Bhattacharya, S., Dutta, S. K., Wang, E., & Mukhopadhyay, D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.293985 · Cited by 77
Allain, B., Jarray, R., Borriello, L., Leforban, B., Dufour, S., Liu, W., Pamonsinlapatham, P., Bianco, S., Larghero, J., Hadj-Slimane, R., et al. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.09.003 · Cited by 77
Yi, Z., Cho, S., Zhao, H., Wu, Y., Luo, J., Li, D., Yi, T., Xu, X., Wu, Z., & Liu, M. (2008) · International Journal of Cancer · doi:10.1002/ijc.24027 · Cited by 77
“In VEGF signaling pathway, ligands bind in an overlapping pattern to 3 cell surface receptor tyrosine kinases, known as VEGF receptor-1, -2 and -3 (VEGFR1-3).(31)”
BackgroundPons, M., & Marin‐Castaño, M. E. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6254 · Cited by 82
“VEGF plays a key role in angiogenesis by regulating endothelial cells proliferation, migration, and survival.(80) Of interest, secretion of VEGF by RPE cells is polarized, as the basal secretion toward Bruch’s membrane is two to seven times higher than the apical secretion toward the photoreceptors.”
BackgroundStepanova, V. V., Jayaraman, P.-S., Zaitsev, S. V., Lebedeva, T., Bdeir, K., Kershaw, R. M., Holman, K. R., Parfyonova, Y. V., Semina, E. V., Beloglazova, I. B., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.678490 · Cited by 83
“VEGF and uPAplay prominent roles in angiogenesis (59, 66).”
BackgroundNeuronal sFlt1 and Vegfaa determine venous sprouting and spinal cord vascularization
Wild, R., Klems, A., Takamiya, M., Hayashi, Y., Strähle, U., Ando, K., Mochizuki, N., van Impel, A., Schulte‐Merker, S., Krueger, J., et al. (2017) · Nature Communications · doi:10.1038/ncomms13991 · Cited by 80
Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development
Bower, N. I., Vogrin, A. J., Guen, L. L., Chen, H., Stacker, S. A., Achen, M. G., & Hogan, B. M. (2017) · Development · doi:10.1242/dev.146969 · Cited by 77
“Our biochemical data show that Vegfd is capable of binding to Kdr but not to Kdrl. Zebrafish Vegfd is capable of rescuing Vegfaa zebrafish mutants (Rossi et al., 2016), which strongly supports our data and together suggests that Vegfd can activate signaling downstream of Kdr.”
BackgroundInfluentialDucoli, L., & Detmar, M. J. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.01.018 · Cited by 82
Teran, M., & Nugent, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.627372 · Cited by 63
“VEGF165, the predominant isoform in humans, exerts its angiogenic effects by binding and activating two cell surface receptor tyrosine kinases, VEGFR-1 and VEGFR-2, expressed in vascular endothelial cells (13).”
BackgroundStimulus-dependent phosphorylation of profilin-1 in angiogenesis
Fan, Y., Arif, A., Gong, Y., Jia, J., Eswarappa, S. M., Willard, B. B., Horowitz, A., Graham, L. M., Penn, M. S., & Fox, P. L. (2012) · Nature Cell Biology · doi:10.1038/ncb2580 · Cited by 80
Goyal, A. K., Poluzzi, C., Willis, C. D., Smythies, J., Shellard, A., Neill, T., & Iozzo, R. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401786 · Cited by 80
“Gene-targeting studies using eNos / mice have shown eNOS plays a key role in VEGFA-induced angiogenesis and vascular permeability in a PI3K/Akt-dependent manner (96).”
BackgroundInfluentialDolečková, I., Rárová, L., Grúz, J., Vondrusová, M., Strnad, M., & Kryštof, V. (2012) · Fitoterapia · doi:10.1016/j.fitote.2012.06.002 · Cited by 76
“Vascular endothelial growth factor receptors (VEGFRs) are among the most important components in molecular pathway of the process of angiogenesis and they include three types of receptor tyrosine kinases: VEGFR1 (Flt-1), VEGFR2 (KDR, Flk-2) and VEGFR3 [36].”
BackgroundTwenty years after ACEIs and ARBs: emerging treatment strategies for diabetic nephropathy
Johnson, S. A., & Spurney, R. F. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00266.2015 · Cited by 79
Caporarello, N., Lupo, G., Olivieri, M., Cristaldi, M., Cambria, M. T., Salmeri, M., & Anfuso, C. D. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7179 · Cited by 84
“It has been reported that VEGF and PlGF could have direct effects on NRP1, independently from the VEGF receptor (12).”
Lammert, E., & Axnick, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006619 · Cited by 75
“Two different ways of blood vessel formation occur in vertebrates: angiogenesis and vasculogenesis (Fong et al. 1999; Olsson et al. 2006; Adams and Alitalo 2007).”
BackgroundNFATc1 regulates lymphatic endothelial development
Kulkarni, R. M., Greenberg, J. M., & Akeson, A. L. (2009) · Mechanisms of Development · doi:10.1016/j.mod.2009.02.003 · Cited by 82
Andrikopoulos, P., Baba, A., Matsuda, T., Djamgoz, M. B. A., Yaqoob, M. M., & Eccles, S. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.251777 · Cited by 73
MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src
Eisenach, P. A., Roghi, C., Fogarasi, M., Murphy, G., & English, W. R. (2010) · Journal of Cell Science · doi:10.1242/jcs.062711 · Cited by 73
“3A), and VEGFR-2 has been shown to associate with phosphorylated Src (Chou et al., 2002; Olsson et al., 2006), we hypothesised that MT1-MMP could be in a complex with VEGFR-2.”
BackgroundCorneal Mesenchymal Stromal Cells Are Directly Antiangiogenic via PEDF and sFLT-1
Eslani, M., Putra, I., Shen, X., Hamouie, J., Afsharkhamseh, N., Besharat, S., Rosenblatt, M. I., Dana, R., Hematti, P., & Djalilian, A. R. (2017) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.17-22680 · Cited by 75
The role of tumor angiogenesis as a therapeutic target in colorectal cancer
Battaglin, F., Puccini, A., Intini, R., Schirripa, M., Ferro, A., Bergamo, F., Lonardi, S., Zagonel, V., Lenz, H., & Loupakis, F. (2018) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2018.1428092 · Cited by 83
Gourlaouen, M., Welti, J. C., Vasudev, N. S., & Reynolds, A. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446401 · Cited by 87
Morbidelli, L., Genah, S., & Cialdai, F. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.720091 · Cited by 78
“In particular, the binding of VEGF-A, secreted by cells in the hypoxic environment, to VEGFR-2 is the major way by which EC migration is promoted (Olsson et al., 2006).”
BackgroundDzamukova, M. R., Brunner, T. M., Miotla‐Zarebska, J., Heinrich, F., Brylka, L., Mashreghi, M., Kusumbe, A. P., Kühn, R., Schinke, T., Vincent, T. L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30618-8 · Cited by 75
Usui, J., Glezerman, I. G., Salvatore, S., Chandran, C. B., Flombaum, C. D., & Seshan, S. V. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.05.015 · Cited by 74
“As specific agents, VEGF inhibitors include a number of neutralizing anti-VEGF antibodies and those that target the VEGF receptors (VEGFRs), the most common being bevacizumab (Avastin), which was approved by the United States Food and Drug Administration (FDA) in 2004 [1].”
BackgroundInfluentialRole of copper in regression of cardiac hypertrophy
Zheng, L., Han, P., Liu, J., Li, R., Yin, W., Wang, T., Zhang, W., & Kang, Y. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.014 · Cited by 76
Minina, S., Reichman‐Fried, M., & Raz, E. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.073 · Cited by 74
Saraswati, S., & Agrawal, S. S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.012 · Cited by 75
Pang, X., Wu, Y., Wu, Y., Lu, B., Chen, J., Wang, J., Yi, Z., Qu, W., & Liu, M. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-0936 · Cited by 74
Noncanonical Activity of Seryl-tRNA Synthetase Is Involved in Vascular Development
Fukui, H., Hanaoka, R., & Kawahara, A. (2009) · Circulation Research · doi:10.1161/circresaha.108.191189 · Cited by 75
Berberine inhibits angiogenesis in glioblastoma xenografts by targeting the VEGFR2/ERK pathway
Jin, F., Xie, T., Huang, X., & Zhao, X. (2018) · Pharmaceutical Biology · doi:10.1080/13880209.2018.1548627 · Cited by 75
“Vascular endothelial growth factor receptor 2 (VEGFR2), also known as kinase insert domain receptor (KDR), is a major mediator of VEGF’s biological effects, and plays a vital role in tumour angiogenesis (Olsson et al. 2006).”
BackgroundInfluentialThe Expression, Regulation, and Biomarker Potential of Glypican-1 in Cancer
Wang, S., Qiu, Y., & Bai, B. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00614 · Cited by 75
“VEGF is a key factor for angiogenesis, one of the essential biological processes for tumorigenesis (53).”
BackgroundNoghero, A., Perino, A., Seano, G., Saglio, E., Sasso, G. L., Veglio, F., Primo, L., Hirsch, E., Bussolino, F., & Morello, F. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.250621 · Cited by 73
“However, treatment of HUVECs with T0901317 blunted the functional activation of VEGFR2 by VEGF-A, as demonstrated by reduced phosphorylation of VEGFR2 on Tyr1175 and by reduced phosphorylation of phospholipase Cγ (PLCγ), a key mediator of VEGFR2dependent angiogenic responses (Figure 4A).(34) VEGF-A– dependent phosphor…”
BackgroundAnti-VEGF therapy: higher potency and long-lasting antagonism are not necessarily better
Usui‐Ouchi, A., & Friedlander, M. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129862 · Cited by 77
Lu, J. C., Santosa, K. B., Jablonka‐Shariff, A., Vannucci, B., Fuchs, A. G., Turnbull, I. R., Pan, D., Wood, M. D., & Snyder‐Warwick, A. K. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1736-20.2020 · Cited by 78
“VegfR2 (or Flk-1), the receptor responsible for initiating downstream Vegf-A pathways, is found in ECs, initiates angiogenesis, and increases vessel permeability (Olsson et al., 2006).”
BackgroundHuang, J., & Xiao, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081586 · Cited by 79
The Role of Periostin in Angiogenesis and Lymphangiogenesis in Tumors
Wasik, A., Ratajczak‐Wielgomas, K., Bądziński, A., Dzięgiel, P., & Podhorska‐Okołów, M. (2022) · Cancers · doi:10.3390/cancers14174225 · Cited by 74
“In turn, the Erk/VEGF pathway is induced by binding of the growth factor VEGF-A to the VEGF-R2 receptor, which results in phosphorylation of phospholipase C gamma (PLC-γ) and activation of MAPK/Erk signaling pathways [100,101].”
BackgroundRole of hydrogen sulphide in physiological and pathological angiogenesis
Zhang, Y., Jing, M., Cai, C., Zhu, S., Zhang, C.-J., Wang, Q., Zhai, Y., Ji, X., & Wu, D. (2022) · Cell Proliferation · doi:10.1111/cpr.13374 · Cited by 79
Yoshida, S., Aihara, K., Ikeda, Y., Sumitomo-Ueda, Y., Uemoto, R., Ishikawa, K., Ise, T., Yagi, S., Iwase, T., Mouri, Y., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001533 · Cited by 76
Lin, C., Lee, H., Fu, C., Ding, Y.-Y., Chen, J.-S., Lee, M.-H., Huang, W.-J., & Tsai, H. (2013) · Nature Communications · doi:10.1038/ncomms3829 · Cited by 77
Wu, J., Strawn, T. L., Luo, M., Wang, L., Li, R., Ren, M., Xia, J., Zhang, Z., Ma, W., Luo, T., et al. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.304554 · Cited by 73
“Critical among these is the activation of endothelial cells, mediated by binding of a vascular endothelial growth factor (VEGF) to its main angiogenic receptor, VEGF receptor-2 (VEGFR-2).(7) A cooperative binding interaction between VEGFR-2 and α V β 3 integrin plays a key role in regulating VEGF signaling in endothel…”
The VEGF/Rho GTPase signalling pathway: A promising target for anti-angiogenic/anti-invasion therapy
van der Meel, R., Symons, M. H., Kudernatsch, R., Kok, R. J., Schiffelers, R. M., Storm, G., Gallagher, W. M., & Byrne, A. T. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.01.005 · Cited by 76
Gao, F., Vasquez, S. X., Su, F., Roberts, S., Shah, N., Grijalva, V. R., Imaizumi, S., Chattopadhyay, A., Ganapathy, E., Meriwether, D., et al. (2011) · Integrative Biology · doi:10.1039/c0ib00147c · Cited by 75
Choi, S.-H., Nam, J.-K., Kim, B., Jang, J.-H., Jin, Y.-B., Lee, H., Park, S. W., Ji, Y. H., Cho, J., & Lee, Y.-J. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0952 · Cited by 75
Glycated Serum Albumin and AGE Receptors
Vetter, S. W. (2015) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.07.005 · Cited by 79
Preclinical evaluation of mesenchymal stem cells overexpressing VEGF to treat critical limb ischemia
Beegle, J. R., Magner, N. L., Kalomoiris, S., Harding, A., Zhou, P., Nacey, C., White, J. L., Pepper, K. A., Gruenloh, W., Annett, G., et al. (2016) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2016.53 · Cited by 74
Soluble VEGFR‐2: an antilymphangiogenic variant of VEGF receptors
Pavlaković, H., Becker, J., Albuquerque, R., Wilting, J., & Ambati, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05714.x · Cited by 73
Engineered microenvironments for synergistic VEGF – Integrin signalling during vascularization
Moulisová, V., González‐García, C., Cantini, M., Rodrigo‐Navarro, A., Weaver, J. D., Costell, M., Serra, R. S. I., Dalby, M. J., García, A. J., & Salmerón‐Sánchez, M. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.02.024 · Cited by 72
“To investigate signalling, we examined phosphorylation of phospholipase C gamma 1 (pPLCg1) as a downstream effector which is activated by VEGFR-2 [4], phosphorylation of focal adhesion kinease (pFAK) that is activated after integrin binding and clustering [28], and phosphorylation of ERK1/2 (pERK1/2) a downstream effe…”
Long Non-Coding RNA Malat1 Regulates Angiogenesis in Hindlimb Ischemia
Zhang, X., Tang, X., Hamblin, M. H., & Yin, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061723 · Cited by 72
“Specifically, the major signaling molecule for angiogenesis is vascular endothelial growth factor (VEGF) which is commonly found to be upregulated in pathological conditions such as cancer and ischemic diseases [10,11].”
BackgroundModi, S. J., & Kulkarni, V. M. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1872417 · Cited by 72
“More specifically, VEGFRs consist of three receptors, namely VEGFR-1 (Flt-1), VEGFR-2 [Flk-1/kinase domain receptor (KDR)], and VEGFR-3 (Flt-4) (Olsson et al., 2006).”
BackgroundBu, M. T., Chandrasekhar, P., Ding, L., & Hugo, W. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108211 · Cited by 83
“It is the main mediator of VEGFA-induced angiogenesis and modulation of vascular permeability (Cross et al., 2003; Ferrara & Adamis, 2016; Olsson et al., 2006; Sakurai, Ohgimoto, Kataoka, Yoshida, & Shibuya, 2005; Terman et al., 1992; Wang, Bove, Simone, & Ma, 2020).”
BackgroundInfluentialKrilleke, D., Ng, Y., & Shima, D. T. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371201 · Cited by 72
Metadata
- Authors
- Olsson, A.-K., Dimberg, A., Kreuger, J., & Claesson-Welsh, L.
- Affiliations
- Uppsala University (SE)
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2006-05
- Volume
- 7
- Issue
- 5
- Pages
- 359-371
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2091774189
- Cited by
- 3,122
- References
- 141
- Citations by year
- 2026: 88 · 2025: 107 · 2024: 116 · 2023: 127 · 2022: 127 · 2021: 158 · 2020: 160 · 2019: 156 · 2018: 156 · 2017: 176 · 2016: 202 · 2015: 184 · 2014: 212 · 2013: 231 · 2012: 190
- FWCI
- 10.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Axon Guidance and Neuronal Signaling
- Keywords
- VEGF receptors, VEGF signaling, VEGFR1, VEGFR2, VEGFR-3, angiogenesis, pathological angiogenesis, vascular development, endothelial cells, signal transduction, anti-angiogenic cancer therapy
- MeSH terms
- Animals, Humans, Stem Cells, Signal Transduction, Neovascularization, Physiologic, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factors, Embryonic Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.